Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Waltraud Fröhlich"'
Autor:
Barbara Meier-Schiesser, MD, PhD, Christine Zecha, MD, Sarah Zierold, MD, Isabel Kolm, MD, Magdalena Röckel, MD, Waltraud Fröhlich, Nora Mittag, MD, Christina Schmitt, MD, Joerg Kumbrink, PhD, Jessica C. Hassel, MD, Carola Berking, MD, Dorothee Nashan, MD, Lars Einar French, MD, Julio Vera-González, PhD, Reinhard Dummer, MD, Katrin Kerl-French, MD, Lucie Heinzerling, MD, MPH
Publikováno v:
JAAD International, Vol 15, Iss , Pp 157-164 (2024)
Background: Although highly efficacious, immune checkpoint inhibitors induce a multitude of immune-related adverse events including lichenoid skin reactions (irLP) that are often therapy-resistant. Objectives: To compare the clinical, histological, a
Externí odkaz:
https://doaj.org/article/51030e89392948efa51788f904e90ecb
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background The role of eosinophils in cancer is not yet completely understood, but patients with eosinophilia show a trend towards longer survival in several types of cancer, including melanoma. However, eosinophil count at initial diagnosis
Externí odkaz:
https://doaj.org/article/a2a9df942c564532ad33bead8d84c1bd
Autor:
Waltraud Fröhlich, Lucie Heinzerling, Beate Husain, Carola Berking, Sabine Schüpferling, Amir-Reza Abolhassani, Michael Erdmann, Michael C. Kirchberger
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose Immune checkpoint inhibitors (ICI) are highly effective in several cancer entities, but also invoke a variety of immune-related adverse events (irAE). These are mostly reversible, but can be life-threatening or even fatal. Currently, the path
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da0222b1be4d02a63de1dc56d3ef543a
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/22122
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/22122
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-7 (2019)
BMC Cancer
BMC Cancer
Background The role of eosinophils in cancer is not yet completely understood, but patients with eosinophilia show a trend towards longer survival in several types of cancer, including melanoma. However, eosinophil count at initial diagnosis of metas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89f8f7fa4a3df0b7b8c18ad88771744a
https://doi.org/10.1186/s12885-019-5384-z
https://doi.org/10.1186/s12885-019-5384-z